The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Crohn’s Disease Diagnostic and Therapeutic Market Research Report 2025
Synopsis
Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals.
The global Crohn’s Disease Diagnostic and Therapeutic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
This market is closely related to the pharmaceutical market.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Crohn’s Disease Diagnostic and Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crohn’s Disease Diagnostic and Therapeutic.
Report Scope
The Crohn’s Disease Diagnostic and Therapeutic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Crohn’s Disease Diagnostic and Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Crohn’s Disease Diagnostic and Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie
Celgene
Genetech
Johnson & Johnson
Pfizer
Prometheus Laboratories
Salix Pharmaceuticals
Takeda Pharmaceutical
Segment by Type
Diagnostics
Treatment
Segment by Application
Hospital
Medical Research Institute
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Crohn’s Disease Diagnostic and Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals.
The global Crohn’s Disease Diagnostic and Therapeutic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
This market is closely related to the pharmaceutical market.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Crohn’s Disease Diagnostic and Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crohn’s Disease Diagnostic and Therapeutic.
Report Scope
The Crohn’s Disease Diagnostic and Therapeutic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Crohn’s Disease Diagnostic and Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Crohn’s Disease Diagnostic and Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie
Celgene
Genetech
Johnson & Johnson
Pfizer
Prometheus Laboratories
Salix Pharmaceuticals
Takeda Pharmaceutical
Segment by Type
Diagnostics
Treatment
Segment by Application
Hospital
Medical Research Institute
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Crohn’s Disease Diagnostic and Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Diagnostics
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Medical Research Institute
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Perspective (2019-2030)
2.2 Crohn’s Disease Diagnostic and Therapeutic Growth Trends by Region
2.2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Region (2019-2024)
2.2.3 Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Region (2025-2030)
2.3 Crohn’s Disease Diagnostic and Therapeutic Market Dynamics
2.3.1 Crohn’s Disease Diagnostic and Therapeutic Industry Trends
2.3.2 Crohn’s Disease Diagnostic and Therapeutic Market Drivers
2.3.3 Crohn’s Disease Diagnostic and Therapeutic Market Challenges
2.3.4 Crohn’s Disease Diagnostic and Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Revenue
3.1.1 Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Revenue (2019-2024)
3.1.2 Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Crohn’s Disease Diagnostic and Therapeutic Revenue
3.4 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio
3.4.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2023
3.5 Crohn’s Disease Diagnostic and Therapeutic Key Players Head office and Area Served
3.6 Key Players Crohn’s Disease Diagnostic and Therapeutic Product Solution and Service
3.7 Date of Enter into Crohn’s Disease Diagnostic and Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Crohn’s Disease Diagnostic and Therapeutic Breakdown Data by Type
4.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Type (2019-2024)
4.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2025-2030)
5 Crohn’s Disease Diagnostic and Therapeutic Breakdown Data by Application
5.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Application (2019-2024)
5.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size (2019-2030)
6.2 North America Crohn’s Disease Diagnostic and Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024)
6.4 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size (2019-2030)
7.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024)
7.4 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size (2019-2030)
8.2 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2019-2024)
8.4 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size (2019-2030)
9.2 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024)
9.4 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size (2019-2030)
10.2 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024)
10.4 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Detail
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Crohn’s Disease Diagnostic and Therapeutic Introduction
11.1.4 Abbvie Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
11.1.5 Abbvie Recent Development
11.2 Celgene
11.2.1 Celgene Company Detail
11.2.2 Celgene Business Overview
11.2.3 Celgene Crohn’s Disease Diagnostic and Therapeutic Introduction
11.2.4 Celgene Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
11.2.5 Celgene Recent Development
11.3 Genetech
11.3.1 Genetech Company Detail
11.3.2 Genetech Business Overview
11.3.3 Genetech Crohn’s Disease Diagnostic and Therapeutic Introduction
11.3.4 Genetech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
11.3.5 Genetech Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Introduction
11.4.4 Johnson & Johnson Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Crohn’s Disease Diagnostic and Therapeutic Introduction
11.5.4 Pfizer Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Prometheus Laboratories
11.6.1 Prometheus Laboratories Company Detail
11.6.2 Prometheus Laboratories Business Overview
11.6.3 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Introduction
11.6.4 Prometheus Laboratories Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
11.6.5 Prometheus Laboratories Recent Development
11.7 Salix Pharmaceuticals
11.7.1 Salix Pharmaceuticals Company Detail
11.7.2 Salix Pharmaceuticals Business Overview
11.7.3 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Introduction
11.7.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
11.7.5 Salix Pharmaceuticals Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Detail
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Introduction
11.8.4 Takeda Pharmaceutical Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
11.8.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Diagnostics
Table 3. Key Players of Treatment
Table 4. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Region (2019-2024)
Table 8. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Region (2025-2030)
Table 10. Crohn’s Disease Diagnostic and Therapeutic Market Trends
Table 11. Crohn’s Disease Diagnostic and Therapeutic Market Drivers
Table 12. Crohn’s Disease Diagnostic and Therapeutic Market Challenges
Table 13. Crohn’s Disease Diagnostic and Therapeutic Market Restraints
Table 14. Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Players (2019-2024)
Table 16. Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Diagnostic and Therapeutic as of 2023)
Table 17. Ranking of Global Top Crohn’s Disease Diagnostic and Therapeutic Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Crohn’s Disease Diagnostic and Therapeutic Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Crohn’s Disease Diagnostic and Therapeutic Product Solution and Service
Table 21. Date of Enter into Crohn’s Disease Diagnostic and Therapeutic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Type (2019-2024)
Table 25. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Type (2025-2030)
Table 27. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Application (2019-2024)
Table 29. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Application (2025-2030)
Table 31. North America Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
Table 46. Abbvie Company Detail
Table 47. Abbvie Business Overview
Table 48. Abbvie Crohn’s Disease Diagnostic and Therapeutic Product
Table 49. Abbvie Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
Table 50. Abbvie Recent Development
Table 51. Celgene Company Detail
Table 52. Celgene Business Overview
Table 53. Celgene Crohn’s Disease Diagnostic and Therapeutic Product
Table 54. Celgene Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
Table 55. Celgene Recent Development
Table 56. Genetech Company Detail
Table 57. Genetech Business Overview
Table 58. Genetech Crohn’s Disease Diagnostic and Therapeutic Product
Table 59. Genetech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
Table 60. Genetech Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Product
Table 64. Johnson & Johnson Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer Crohn’s Disease Diagnostic and Therapeutic Product
Table 69. Pfizer Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Prometheus Laboratories Company Detail
Table 72. Prometheus Laboratories Business Overview
Table 73. Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Product
Table 74. Prometheus Laboratories Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
Table 75. Prometheus Laboratories Recent Development
Table 76. Salix Pharmaceuticals Company Detail
Table 77. Salix Pharmaceuticals Business Overview
Table 78. Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Product
Table 79. Salix Pharmaceuticals Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
Table 80. Salix Pharmaceuticals Recent Development
Table 81. Takeda Pharmaceutical Company Detail
Table 82. Takeda Pharmaceutical Business Overview
Table 83. Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Product
Table 84. Takeda Pharmaceutical Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
Table 85. Takeda Pharmaceutical Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Type: 2023 VS 2030
Figure 3. Diagnostics Features
Figure 4. Treatment Features
Figure 5. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Medical Research Institute Case Studies
Figure 9. Other Case Studies
Figure 10. Crohn’s Disease Diagnostic and Therapeutic Report Years Considered
Figure 11. Global Crohn’s Disease Diagnostic and Therapeutic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Crohn’s Disease Diagnostic and Therapeutic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Region: 2023 VS 2030
Figure 14. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Players in 2023
Figure 15. Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Diagnostic and Therapeutic as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2023
Figure 17. North America Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2019-2030)
Figure 19. United States Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2019-2030)
Figure 23. Germany Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Share by Region (2019-2030)
Figure 31. China Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2019-2030)
Figure 39. Mexico Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2019-2030)
Figure 43. Turkey Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Abbvie Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
Figure 46. Celgene Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
Figure 47. Genetech Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
Figure 48. Johnson & Johnson Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
Figure 50. Prometheus Laboratories Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
Figure 51. Salix Pharmaceuticals Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
Figure 52. Takeda Pharmaceutical Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
